Autochthonous case of dengue in France, October 2013

Eurosurveillance

Volumn 18, Issue 50, 2013, Pages

  Marchand, E ^a   Prat, C ^b   Jeannin, C ^c   Lafont, E ^d   Bergmann, T ^a   Flusin, O ^b   Rizzi, J ^d   Roux, N ^d   Busso, V ^e   Deniau, J ^f   Noel, H ^g   Vaillant, V ^g   Leparc Goffart, I ^b   Six, C ^a   Paty, M C ^g  

^a Regional office of the French Institute for Public Health Surveillance (Cire Sud)   (France)

^b INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^c Entente Interdepartementale pour la Demoustication du Littoral Mediterraneen   (France)

^d The Regional Health Observatory of Provence Alpes Cote d'Azur   (France)

^e Laboratory Network Bioactif   (France)

^f Emergency services regional observatory of Provence Alpes Côte d'Azur   (France)

^g INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NONSTRUCTURAL PROTEIN 1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIGEN;

ADULT; AEDES ALBOPICTUS; ARTICLE; BLOOD SAMPLING; CASE REPORT; DENGUE; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFECTION CONTROL; MYALGIA; PAIN; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; VECTOR CONTROL; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION; BLOOD; FEMALE; FRANCE; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; OCCUPATIONAL EXPOSURE; SEROTYPING; TRANSMISSION; DISEASE TRANSMISSION;

ADULT; ANTIGENS, VIRAL; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRANCE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; OCCUPATIONAL EXPOSURE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTYPING;

EID: 84890398827     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2013.18.50.20661     Document Type: Article

References (21)

1. World Health Organization (WHO). Guidelines for plaque reduction neutralization testing of human antibodies to dengue viruses. Geneva: WHO; 2007. WHO/IVB/07.07. Available from:http://whqlibdoc.who.int/hq/2007/who_ivb_07.07_eng.pdf
2. Gautret P, Cramer JP, Field V, Caumes E, Jensenius M, Gkrania-Klotsas E, et al. Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010. Euro Surveill. 2012;17(26):pii=20205. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20205
3. World Health Organization (WHO). Dengue: guidelines for diagnosis, treatment, prevention and control. Geneva: WHO; 2009. WHO/HTM/NTD/DEN/2009.1. Available from:http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf
4. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504-7. http://dx.doi.org/10.1038/nature12060 PMid:23563266 PMCid:PMC3651993
5. Schaffner F, Medlock JM, Van Bortel W. Public health significance of invasive mosquitoes in Europe. Clin Microbiol Infect. 2013;19(8):685-92. http://dx.doi.org/10.1111/1469-0691.12189 PMid:23574618
6. Paupy C, Delatte H, Bagny L, Corbel V, Fontenille D. Aedes albopictus, an arbovirus vector: from the darkness to the light. Microbes Infect. 2009;11(14-15):1177-85. http://dx.doi.org/10.1016/j.micinf.2009.05.005 PMid:19450706
7. La Ruche G, Souarès Y, Armengaud A, Peloux-Petiot F, Delaunay P, Desprès P, et al. First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill. 2010;15(39):pii=19676. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19676 PMid:20929659
8. Schmidt-Chanasit J, Haditsch M, Schöneberg I, Günther S, Stark K, Frank C. Dengue virus infection in a traveller returning from Croatia to Germany. Euro Surveill. 2010;15(40):pii=19677. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19677 PMid:20946759
9. Alves MJ, Fernandes PL, Amaro F, Osório H, Luz T, Parreira P, et al. Clinical presentation and laboratory findings for the first autochthonous cases of dengue fever in Madeira island, Portugal, October 2012. Euro surveill. 2013;18(6):pii=20398. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20398 PMid:23410256
10. Delaunay P, Mathieu B, Marty P, Fauran P, Schaffner F. [Chronology of the development of Aedes albopictus in the Alpes-Maritimes Department of France, from 2002 to 2005]. Med Trop (Mars). 2007;67(3):310-1. French.
11. Delaunay P, Jeannin C, Schaffner F, Marty P. [News on the presence of the tiger mosquito Aedes albopictus in metropolitan France]. Arch Pediatr. 2009;16 Suppl 2:S66-S71. French. http://dx.doi.org/10.1016/S0929-693X(09)75304-7
12. Instruction N DGS/RI1/2013/182 du 30 avril 2013 mettant à jour le guide relatif aux modalités de mise en oeuvre du plan anti-dissémination du chikungunya et de la dengue en métropole. [Order updating the French preparedness and response plan against expansion of chikungunya and dengue fever in mainland France]. Paris: Ministry of health; 2013. French. Available from:http://circulaires.legifrance.gouv.fr/pdf/2013/05/cir_37044.pdf
13. Décret n 2006-433 du 24 April 2006 complétant la liste des maladies faisant l'objet d'une transmission obligatoire de données individuelles à l'autorité sanitaire. [Decree updating the list of statutory notified diseases with transmission of individual data to the health authority]. Paris: République française; 2006. Available from:http://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000000455594
14. Clark BM, Molton JS, Habib T, Williams DT, Weston EL, Smith DW. Dengue virus infection in Australia following occupational exposure: a reflection of increasing numbers of imported cases. J Clin Virol. 2012;54(4):376-7. http://dx.doi.org/10.1016/j.jcv.2012.04.012 PMid:22621878
15. Nemes Z, Kiss G, Madarassi EP, Peterfi Z, Ferenczi E, Bakonyi T, et al. Nosocomial transmission of dengue. Emerg Infect Dis. 2004;10(10):1880-1. http://dx.doi.org/10.3201/eid1010.040464 PMid:15515246 PMCid:PMC3323269
16. Wagner D, de With K, Huzly D, Hufert F, Weidmann M, Breisinger S, et al. Nosocomial acquisition of dengue. Emerg Infect Dis. 2004;10(10):1872-3. http://dx.doi.org/10.3201/eid1010.031037 PMid:15504282 PMCid:PMC3323263
17. Situation épidémiologique de la dengue en Guadeloupe. Point au 27 novembre 2013. [Epidemiological situation of dengue fever in Guadeloupe. November 27th, 2013]. Fort-de-France, Martinique, Saint-Maurice: Institut de Veille Sanitaire; 2013. French. Available from: http://www.invs.sante.fr/fr/content/download/80339/292895/version/35/file/pe_dengue_guadeloupe_271113.pdf
18. Chan M, Johansson MA. The incubation periods of Dengue viruses. PLoS One. 2012;7(11):e50972. http://dx.doi.org/10.1371/journal.pone.0050972 PMid:23226436 PMCid:PMC3511440
19. Tang Y, Kou Z, Zhang F, Yao X, Liu S, Ma J, et al. Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 Infection among adult Chinese patients. PLoS One. 5(12):e15631. http://dx.doi.org/10.1371/journal.pone.0015631 PMid:21206915 PMCid:PMC3012067
20. Duyen HT, Ngoc TV, Ha T, Hang VT, Kieu NT, Young PR, et al. Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status. J Infect Dis. 2011;203(9):1292-300. http://dx.doi.org/10.1093/infdis/jir014 PMid:21335562 PMCid:PMC3069728
21. Duong V, Ly S, Lorn P, Tuiskunen A, Ong S, Chroeung N, et al. Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. PLoS Negl Trop Dis. 2011;5(7):e1244. http://dx.doi.org/10.1371/journal.pntd.0001244 PMid:21811645 PMCid:PMC3139664